. . . "Humans and other mammals"@en . "(2,3-Dichloro-4-(2-thenoyl)phenoxy)acetic acid"@en . "Acidum tienilicum"@en . . . "(2,3-Dichloro-4-(2-thiophenecarbonyl)phenoxy)acetic acid"@en . "# Manier JW, Chang WW, Kirchner JP, Beltaos E: Hepatotoxicity associated with ticrynafen--a uricosuric diuretic. Am J Gastroenterol. 1982 Jun;77(6):401-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/7091125"@en . . "Tienilic acid"@en . . "For the treatment of hypertension."@en . . "Thienylic acid"@en . . " "@en . . . . "4-(2-Thienylketo)-2,3-dichlorophenoxyacetic acid"@en . . "(2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy)acetic acid"@en . . . . "Acide tienilique"@en . . . . "withdrawn"@en . . . . . "Harold Graboyes, \"Method for preparing ticrynafen.\" U.S. Patent US4107179, issued April, 1977."@en . . . "Acido tienilico"@en . . . . . . "4-(2-Theonyl)-2,3-dichlorphenoxyessigsaeure"@en . . . . . "Ticrynafen"@en . "40180-04-9"@en . . . . . "Tienilico acido"@en . . "Ticrynafen, or tienilic acid, is a diuretic drug with uric acid-lowering (uricosuric) action, formerly marketed for the treatment of hypertension. It was withdrawn in 1982, shortly after its introduction to the market, after case reports in the United States indicated a link between the use of ticrynafen and hepatitis. (Manier et al., 1982)"@en .